Quest Diagnostics Incorporated · NYSE:DGX
Delaney Mark E received 2,615 Quest Diagnostics Incorporated shares as an award (Form 4)
Traded Nov 3, 2026 · Filed Nov 5, 2026
On Nov 3, 2026, Delaney Mark E (SVP & Chief Commercial Officer) received 2,615 Quest Diagnostics Incorporated shares as an award, leaving 12,975 shares. Filed Nov 5, 2026 (Form 4).
- Awarded
- 2,615 shares
- Holding after
- 12,975 shares
- Trading plan
- No
- Role
- SVP & Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Common Stock | Award | 2,615 | 12,975 | Direct |
Source
Download original · View original at SEC
Related
- Quest Diagnostics Incorporated
- Delaney Mark E
- Quest Diagnostics Incorporated shareholders
- Form 4 · Delaney Mark E · Oct 23, 2026
- Form 4 · Delaney Mark E · Jul 29, 2026
- Form 4 · Delaney Mark E · Jul 27, 2026
- Form 4 · Delaney Mark E · Apr 24, 2026
- Form 4 · Deppe Michael J · Nov 16, 2026
- Form 4 · Plewman Patrick · Nov 12, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Form 4 · Ramachandran Subu · Nov 5, 2026
- Form 4 · Doherty Catherine T. · Nov 5, 2026